Cargando…

Identification and Subtyping of Cryptosporidium parvum and Cryptosporidium hominis in Cancer Patients, Isfahan Province, Central Iran

BACKGROUND: Cryptosporidium spp. are protozoan parasites that cause diarrhea in humans and animals. Subtyping data about Cryptosporidium spp. in Isfahan, Iran is limited; therefore, we aimed to study the prevalence rate of Cryptosporidium spp. in cancer patients, associated risk factors, and subtype...

Descripción completa

Detalles Bibliográficos
Autores principales: Pestechian, Nader, Mohammadi Manesh, Reza, Tavakoli, Sanaz, Mokarian, Fariborz, Rahmani, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825695/
https://www.ncbi.nlm.nih.gov/pubmed/36694568
http://dx.doi.org/10.18502/ijpa.v17i4.11277
_version_ 1784866677566996480
author Pestechian, Nader
Mohammadi Manesh, Reza
Tavakoli, Sanaz
Mokarian, Fariborz
Rahmani, Maryam
author_facet Pestechian, Nader
Mohammadi Manesh, Reza
Tavakoli, Sanaz
Mokarian, Fariborz
Rahmani, Maryam
author_sort Pestechian, Nader
collection PubMed
description BACKGROUND: Cryptosporidium spp. are protozoan parasites that cause diarrhea in humans and animals. Subtyping data about Cryptosporidium spp. in Isfahan, Iran is limited; therefore, we aimed to study the prevalence rate of Cryptosporidium spp. in cancer patients, associated risk factors, and subtypes of Cryptosporidium spp. METHODS: Fecal samples were collected from 187 cancer patients from the Oncology Department of Seyed-al-Shohada Hospital, Isfahan University of Medical Sciences during 2014–2020 and screened for Cryptosporidium spp. using microscopical techniques. Nested PCR amplifying 18S rRNA gene was used to detect Cryptosporidium spp. in samples, followed by subtyping using nested PCR amplifying gp60 sequences. RESULTS: Overall, the rate of infection with Cryptosporidium spp. was 4.3% (n=8). Five samples out of eight samples were identified as Cryptosporidium spp. using a nested PCR for the 18S rRNA gene, two subtypes of C. parvum named IIaA18G3R1 (n = 2) and IIaA17G2R1 (n = 2), and one subtype of C. hominis named IbA6G3 were identified by sequencing of the gp60. The IbA6G3 subtype has rarely been detected in other investigations. CONCLUSION: This is the first survey on the subtyping of Cryptosporidium spp. in this region. The results of the present survey show both zoonotic and anthroponotic transmission routes in the region.
format Online
Article
Text
id pubmed-9825695
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-98256952023-01-23 Identification and Subtyping of Cryptosporidium parvum and Cryptosporidium hominis in Cancer Patients, Isfahan Province, Central Iran Pestechian, Nader Mohammadi Manesh, Reza Tavakoli, Sanaz Mokarian, Fariborz Rahmani, Maryam Iran J Parasitol Original Article BACKGROUND: Cryptosporidium spp. are protozoan parasites that cause diarrhea in humans and animals. Subtyping data about Cryptosporidium spp. in Isfahan, Iran is limited; therefore, we aimed to study the prevalence rate of Cryptosporidium spp. in cancer patients, associated risk factors, and subtypes of Cryptosporidium spp. METHODS: Fecal samples were collected from 187 cancer patients from the Oncology Department of Seyed-al-Shohada Hospital, Isfahan University of Medical Sciences during 2014–2020 and screened for Cryptosporidium spp. using microscopical techniques. Nested PCR amplifying 18S rRNA gene was used to detect Cryptosporidium spp. in samples, followed by subtyping using nested PCR amplifying gp60 sequences. RESULTS: Overall, the rate of infection with Cryptosporidium spp. was 4.3% (n=8). Five samples out of eight samples were identified as Cryptosporidium spp. using a nested PCR for the 18S rRNA gene, two subtypes of C. parvum named IIaA18G3R1 (n = 2) and IIaA17G2R1 (n = 2), and one subtype of C. hominis named IbA6G3 were identified by sequencing of the gp60. The IbA6G3 subtype has rarely been detected in other investigations. CONCLUSION: This is the first survey on the subtyping of Cryptosporidium spp. in this region. The results of the present survey show both zoonotic and anthroponotic transmission routes in the region. Tehran University of Medical Sciences 2022 /pmc/articles/PMC9825695/ /pubmed/36694568 http://dx.doi.org/10.18502/ijpa.v17i4.11277 Text en Copyright © 2022 Pestechian et al. Published by Tehran University of Medical Sciences https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited.
spellingShingle Original Article
Pestechian, Nader
Mohammadi Manesh, Reza
Tavakoli, Sanaz
Mokarian, Fariborz
Rahmani, Maryam
Identification and Subtyping of Cryptosporidium parvum and Cryptosporidium hominis in Cancer Patients, Isfahan Province, Central Iran
title Identification and Subtyping of Cryptosporidium parvum and Cryptosporidium hominis in Cancer Patients, Isfahan Province, Central Iran
title_full Identification and Subtyping of Cryptosporidium parvum and Cryptosporidium hominis in Cancer Patients, Isfahan Province, Central Iran
title_fullStr Identification and Subtyping of Cryptosporidium parvum and Cryptosporidium hominis in Cancer Patients, Isfahan Province, Central Iran
title_full_unstemmed Identification and Subtyping of Cryptosporidium parvum and Cryptosporidium hominis in Cancer Patients, Isfahan Province, Central Iran
title_short Identification and Subtyping of Cryptosporidium parvum and Cryptosporidium hominis in Cancer Patients, Isfahan Province, Central Iran
title_sort identification and subtyping of cryptosporidium parvum and cryptosporidium hominis in cancer patients, isfahan province, central iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825695/
https://www.ncbi.nlm.nih.gov/pubmed/36694568
http://dx.doi.org/10.18502/ijpa.v17i4.11277
work_keys_str_mv AT pestechiannader identificationandsubtypingofcryptosporidiumparvumandcryptosporidiumhominisincancerpatientsisfahanprovincecentraliran
AT mohammadimaneshreza identificationandsubtypingofcryptosporidiumparvumandcryptosporidiumhominisincancerpatientsisfahanprovincecentraliran
AT tavakolisanaz identificationandsubtypingofcryptosporidiumparvumandcryptosporidiumhominisincancerpatientsisfahanprovincecentraliran
AT mokarianfariborz identificationandsubtypingofcryptosporidiumparvumandcryptosporidiumhominisincancerpatientsisfahanprovincecentraliran
AT rahmanimaryam identificationandsubtypingofcryptosporidiumparvumandcryptosporidiumhominisincancerpatientsisfahanprovincecentraliran